- Home
- TRX vs JSPR Comparison
TRX vs JSPR Comparison
Compare TRX & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRX
- JSPR
- Stock Information
- Founded
- TRX 1990
- JSPR 2018
- Country
- TRX Canada
- JSPR United States
- Employees
- TRX N/A
- JSPR N/A
- Industry
- TRX
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRX
- JSPR Health Care
- Exchange
- TRX Nasdaq
- JSPR Nasdaq
- Market Cap
- TRX 94.5M
- JSPR 85.8M
- IPO Year
- TRX N/A
- JSPR N/A
- Fundamental
- Price
- TRX $0.34
- JSPR $3.51
- Analyst Decision
- TRX Strong Buy
- JSPR Buy
- Analyst Count
- TRX 1
- JSPR 12
- Target Price
- TRX $1.50
- JSPR $31.67
- AVG Volume (30 Days)
- TRX 404.8K
- JSPR 1.4M
- Earning Date
- TRX 07-22-2025
- JSPR 08-12-2025
- Dividend Yield
- TRX N/A
- JSPR N/A
- EPS Growth
- TRX N/A
- JSPR N/A
- EPS
- TRX N/A
- JSPR N/A
- Revenue
- TRX $45,405,000.00
- JSPR N/A
- Revenue This Year
- TRX $51.45
- JSPR N/A
- Revenue Next Year
- TRX $26.19
- JSPR N/A
- P/E Ratio
- TRX N/A
- JSPR N/A
- Revenue Growth
- TRX 26.50
- JSPR N/A
- 52 Week Low
- TRX $0.27
- JSPR $2.27
- 52 Week High
- TRX $0.45
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- TRX 54.18
- JSPR 37.54
- Support Level
- TRX $0.33
- JSPR $2.71
- Resistance Level
- TRX $0.35
- JSPR $4.00
- Average True Range (ATR)
- TRX 0.01
- JSPR 0.67
- MACD
- TRX -0.00
- JSPR -0.28
- Stochastic Oscillator
- TRX 50.50
- JSPR 29.21
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.